| Calcineurin inhibitors: 40 years later, can’t live without… JR Azzi, MH Sayegh, SG Mallat The Journal of Immunology 191 (12), 5785-5791, 2013 | 351 | 2013 |
| Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma O Zavidij, NJ Haradhvala, TH Mouhieddine, R Sklavenitis-Pistofidis, S Cai, ... Nature cancer 1 (5), 493-506, 2020 | 247 | 2020 |
| Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response LL Cunha, SF Perazzio, J Azzi, P Cravedi, LV Riella Frontiers in immunology 11, 553905, 2020 | 231 | 2020 |
| Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes M Jurewicz, S Yang, A Augello, JG Godwin, RF Moore, J Azzi, P Fiorina, ... Diabetes 59 (12), 3139-3147, 2010 | 173 | 2010 |
| CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor–based regimen versus a CNI-based regimen: a systematic review and meta-analysis of … SG Mallat, BY Tanios, HS Itani, T Lotfi, C McMullan, S Gabardi, EA Akl, ... Clinical Journal of the American Society of Nephrology 12 (8), 1321-1336, 2017 | 125 | 2017 |
| Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave A Al Jurdi, L Morena, M Cote, E Bethea, J Azzi, LV Riella American Journal of Transplantation 22 (12), 3130-3136, 2022 | 117 | 2022 |
| Integrated kidney exosome analysis for the detection of kidney transplant rejection J Park, HY Lin, JP Assaker, S Jeong, CH Huang, A Kurdi, K Lee, K Fraser, ... ACS nano 11 (11), 11041-11046, 2017 | 112 | 2017 |
| Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site M Ben Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, ... Acta diabetologica 52, 917-927, 2015 | 111 | 2015 |
| Polylactide-cyclosporin A nanoparticles for targeted immunosuppression J Azzi, L Tang, R Moore, R Tong, N El Haddad, T Akiyoshi, B Mfarrej, ... The FASEB Journal 24 (10), 3927, 2010 | 104 | 2010 |
| Blocking IFNAR1 inhibits multiple myeloma–driven Treg expansion and immunosuppression Y Kawano, O Zavidij, J Park, M Moschetta, K Kokubun, TH Mouhieddine, ... The Journal of clinical investigation 128 (6), 2487-2499, 2018 | 95 | 2018 |
| Targeted delivery of immunomodulators to lymph nodes J Azzi, Q Yin, M Uehara, S Ohori, L Tang, K Cai, T Ichimura, M McGrath, ... Cell reports 15 (6), 1202-1213, 2016 | 93 | 2016 |
| Antibody-dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab AT Kurdi, SV Glavey, NA Bezman, A Jhatakia, JL Guerriero, S Manier, ... Molecular cancer therapeutics 17 (7), 1454-1463, 2018 | 92 | 2018 |
| A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection MM Kaminski, MA Alcantar, IT Lape, R Greensmith, AC Huske, JA Valeri, ... Nature biomedical engineering 4 (6), 601-609, 2020 | 89 | 2020 |
| Multiple myeloma and the immune microenvironment Y Kawano, M Roccaro, I M Ghobrial, J Azzi Current cancer drug targets 17 (9), 806-818, 2017 | 78 | 2017 |
| PI3kα and STAT1 interplay regulates human mesenchymal stem cell immune polarization M Mounayar, E Kefaloyianni, B Smith, Z Solhjou, OH Maarouf, J Azzi, ... Stem cells 33 (6), 1892-1901, 2015 | 76 | 2015 |
| Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival B Bahmani, M Uehara, L Jiang, F Ordikhani, N Banouni, T Ichimura, ... The Journal of clinical investigation 128 (11), 4770-4786, 2018 | 75 | 2018 |
| Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts LV Riella, T Watanabe, PT Sage, J Yang, M Yeung, J Azzi, V Vanguri, ... American journal of transplantation 11 (4), 832-840, 2011 | 70 | 2011 |
| Mesenchymal stem cells express serine protease inhibitor to evade the host immune response N El Haddad, D Heathcote, R Moore, S Yang, J Azzi, B Mfarrej, ... Blood, The Journal of the American Society of Hematology 117 (4), 1176-1183, 2011 | 63 | 2011 |
| Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer PS Karia, JR Azzi, EC Heher, VM Hills, CD Schmults JAMA dermatology 152 (5), 533-540, 2016 | 62 | 2016 |
| Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice E Sula Karreci, H Fan, M Uehara, AB Mihali, PK Singh, AT Kurdi, ... Proceedings of the National Academy of Sciences 113 (52), E8425-E8432, 2016 | 61 | 2016 |
